A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

BACKGROUND: Non-small cell lung cancer (NSCLC) imposes a substantial burden on patients, health care systems and society due to increasing incidence and poor survival rates. In recent years, advances in the treatment of metastatic NSCLC have resulted from the introduction of targeted therapies. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Ansgar, Prenzler, Anne, Frank, Martin, Golpon, Heiko, Welte, Tobias, von der Schulenburg, J-Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269853/
https://www.ncbi.nlm.nih.gov/pubmed/25471553
http://dx.doi.org/10.1186/1471-2466-14-192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269853/
https://www.ncbi.nlm.nih.gov/pubmed/25471553
http://dx.doi.org/10.1186/1471-2466-14-192

Ejemplares similares